Introduction to a special issue on Geroscience
It is with distinct pleasure to introduce this September issue of Aging Medicine as a special issue dedicated to the International Geroscience Symposium entitled "Aging Mechanisms and Interventions that Impact Senior Health" held on May 24-25, 2019 in Shenzhen, China.
The Symposium was the first in a series of seven international geroscience conferences bringing together researchers from around the world to advance the revolutionary approach to healthy aging known as geroscience. It was held in conjunction with the 2019 annual scientific meeting of Chinese Medical Association Geriatrics Branch and China National Center of Geriatrics and Gerontology.
The Symposium provided a truly unique and important international platform for promoting geroscience and brainstorming on its further development in China, the country with the world's largest aging population.
Aging itself alone, by far, is the greatest risk factor for almost all chronic conditions including frailty and disability in older adults.
Geroscience aims to gain in-depth understanding of biology and mechanisms of with the hypothesis that therapeutically addressing aging and its mechanisms directly will simultaneously prevent the onset or mitigate the severity of multiple chronic diseases (Figure 1 1 ). This is innovative and much more efficient that the traditional approach of addressing one disease at a time. It also helps promote healthspan with profound medical, policy and socioeconomic impact. 2 In 2011, the US National Institutes of Health (NIH) launched the Trans-NIH Geroscience Interest Group (GSIG), which was initiated and led by the National Institute on Aging (NIA) with participation of 22 NIH institutes and centers. 3 GSIG has since become a major driving force for advancing basic and translational aging research in the US. Among other symposia and conferences, GSIG has launched two major summits in the US, one entitled "Advances in geroscience: impact on healthspan and chronic disease" in 2013 and another entitled "Disease drivers of aging" in 2016 with high profile scholarly exchanges and research presentations as well as high impact scientific publications. 1, 4 NIH has also provided funding to promote geroscience research (RFA AG-16-020, 3 ). Moreover, China-home to more older adults than any other nation on our planet-sends a powerful message to the global research community". 5 With the largest aging population in the world, the demographic shift in China is considered as a "tsunami", whereas such shifts in many other countries are often referred to as "waves". In China, the number of older adults (aged >60 years) reached 250 million at the end of 2018 and is projected to reach 487 million by 2053.
In addition, those aged 80 and older reached 28 million at the end of 2018 and is projected to grow at a rate of one million per year.
The Chinese government is acutely aware of this aging imperative.
While the development of a geriatrics workforce and clinical services is emphasized, including a number of national policies issued by the central Chinese government on senior healthcare and support 6, 7 government investment in geroscience has also been impressive. Presentations by each of the expert speakers at the symposium were structured in a way that speakers provided the audience with a high level view of key facts and conceptual issues as they related to their research area rather than sharing latest research findings as it would be the case at a Gordon, Keystone, or other research conferences. To promote active discussion and brain storming on these key geroscience topics, at least 45 minutes were allocated at the end of each scientific session as well as the entire eighth/last session of 2 hours for discussion. In this special issue of Aging Medicine, we are 
